Live feed
·
PRReleasevia Quantisnow
GRI Bio Inc. logo

GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF

ByQuantisnow·Wall Street's wire, on your screen.
GRI· GRI Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GRI (GRI Bio Inc.) and more on Quantisnow.